Title of article
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Author/Authors
Raj S Padwal، نويسنده , , Sumit R Majumdar، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
7
From page
71
To page
77
Abstract
Summary
Antiobesity treatment is recommended for selected patients in whom lifestyle modification is unsuccessful. Two antiobesity drugs are currently licensed for long-term use. Orlistat, a gastrointestinal lipase inhibitor, reduces weight by around 3 kg
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
590731
Link To Document